Literature DB >> 11209031

Pharmacokinetic of nevirapine in haemodialysis.

H Izzedine, V Launay-Vacher, G Aymard, M Legrand, G Deray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11209031     DOI： 10.1093/ndt/16.1.192

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

2.  Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.

Authors:  Yoninah S Cramer; Susan L Rosenkranz; Stephen D Hall; Lynda A Szczech; Valerianna Amorosa; Samir K Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

3.  Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations.

Authors:  Javier Ena; Concepción Amador; Conxa Benito; Francisco Pasquau
Journal:  HIV AIDS (Auckl)       Date:  2012-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.